Bertrand Jean-Claude | MI4 - McGill University
Loop | Bertrand Jean-claude
mcgillradiobiology.ca
Brain cancer: An intelligent molecule to fool and kill glioblastoma cells | McGill University Health Centre
Leadership and Management - Research Institute of the McGill University Health Centre - RI-MUHC
McGill Oncology - Dr. Bertrand Jean-Claude and a team of... | Facebook
Anne-Laure Larroque (Lombard) - Drug Discovery Platform Research Associate - The Research Institute of the McGill University Health Centre | LinkedIn
McGill Oncology - Dr. Bertrand Jean-Claude and a team of... | Facebook
PDF) Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
Brain cancer: An intelligent molecule to fool and kill glioblastoma cells | McGill University Health Centre
Hafiz Muhammad ALI
Biological Effects of AL622, a Molecule Rationally Designed to Release an EGFR and a câ•'Src Kinase Inhibitor
Dr. Jean-Claude Bertrand - Research Grant - 2011 - Brain Tumour Foundation of Canada
Performance of Knowledge-Based Radiation Therapy Planning for the Glioblastoma Disease Site
Leadership and Management - Research Institute of the McGill University Health Centre - RI-MUHC
Dr Bertrand J Jean Claude McGill - YouTube
Brain cancer: An intelligent molecule to fool and kill glioblastoma cells | Health | thesuburban.com
jean-claude BERTRAND | McGill University, Montréal | McGill
Dr. Bertrand J. Jean-Claude - Director at the Research Institute of the MUHC - McGill - YouTube
Audrey Burban (@audrey_burban) / Twitter
Drug Discovery - Research Institute of the McGill University Health Centre - RI-MUHC
In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N- Acetoxymethyl Carbamate-Containing Combi-Molecule
Dr. Bertrand Jean-Claude | Division of Experimental Medicine - McGill University
jean-claude BERTRAND | McGill University, Montréal | McGill
